Checkpoint Therapeutics Inc (CKPT) Opciones

Man , we need something positive from management here ! 

Well, the problem is we have no communication from mgt regarding the plan after approval. Are they applying to other RAs for approval? what is expected revenue based first approval and second approval and so on......

You cannot leave these crucial updates untouched and expect the MC increases. I think Mgt and BOD need a wake up calls.

We might as well not have gotten the drug approved! 

Thx for your input
Does anyone knows the projected revenue. Tia

It will go . Prob slower than we like . I prefer the solo approach that will take even longer.

Lots of the path forward will come down to daddy Fortress. If we are their golden child--there is no worry. They might decide to favor another and treat us like the redhead step child.

Happy New Year!!!!!!!!!!!!!!! (early--just like PDUFA)

Thanks sword man. Just hope we get this thing moving forward in 2025. Happy new year !! 

Don't really do guesses on a stock price.

Will proj diff if Unloxcyt becomes the go to/SOC vs being 1 of the tricks in bag . Will proj diff if they go solo vs giving away revenue for dist pards etc. Will proj diff if they merge. ETC

Here is 1 possible scenario and how others see hypothetical merge

Any thoughts on where this could goo sword ?? 

💯

Do you own shares wordman ?? 

You must be flipper only or have ZERO situational awareness

I would be happy with 10 bucks !!

Totally agree Tyrus !! Thank you !

Sellers at $3.50 are off playing the next hotcstock, basically playing musical chairs vs a sudden buyout or partnership announcement from Checkpoint.that could send this to $90 overnight.
I say $90 because that is what it would cost Gilead, Elizabeth Lily, Pfizer, Merck or whoever else to buy out Checkpoint's $48M shares for $4.4 billion. In order to get possession of Unloxcyt and its $500M to $1B per year patent protected annual revenues.
$4.4B was what Gilead paid to buy up all the 114M outstanding shares of Cymabay, at $32 per share, to gain possession of CBAY's one liver inflammation drug, Seladelpar that is projected to do $500M to $1B in annual sales revenue.

It's a waiting game with CKPT but $3.50 is insanely low. 

Strangest dam stock on the planet 

Merry Christmas!

Merry Christmas V

After hours trading goes until 5 p.m. today according to the NYSE website. 
This stock's story is now one of being undervalued because of the FDA approved cancer drug asset.
It's just a question of how fast, or slowly it rises from here. I believe.
I'm liking the beginning of the stair step upward pattern, from $2.25 to $4.50 (doubled) , retraced 60 percent (of $2.25 move), to briefly touch $3.15 (another great entry point), and now appears to be climbing again toward a doubling of $3.15 to the next likely resistance level at/around $6.
Etc. etc etc...
As a bonus, Checkpoint has more positive news brewing from their pipeline, namely with cosibelimab, which could potentially propel the stock even further.
Beautiful thing!

Yep. A direction from the company. You got an approval. What is your next move?

The market is waiting on something to move this stock forward ??? 

Thanks Tyrus , aippreciate your response . I like your target price !! Merry Christmas 

Yes I am. I'm in for a short term, say two months, price target of $15.

CKPT reminds me of EBS in several ways, including outstanding shares total.
 When EBS (the Narcan company) was in the $3s last spring, they made a bunch of in-house management structure moves to ensure a switch to profitability. The stock price rose significantly from there.
 The reason for the switch to near future likely profitability with Checkpoint is different, FDA approval of a cancer drug, but I'm expecting the impact on share price to mimic the EBS chart pattern of May, June, and July of this past year. 

Thanks tyrus! Are you  current shareholder?? 

"dumped" is being disingenuous. Two insiders had to sell a small percentage of their shares to satisfy end of year tax requirements as they specified. And the ceo apparently put 900K shares in a trust for his minor children as a Christmas gift, which obviously ought to be viewed as a hugely bullish longterm value indicator.

Looks like some insiders dumped shares ??? 

Exactly. They should have prepared an update already.

It's clear that the market needs an update ! 

Let's hope they have some communication in store for us 

Exactly. If they want to attract more investors they need to step up their communications. Otherwise this is a good candidate for flipping many times.

Thanks Zadie, we could use some communication for sure 

I don't know where this going. But, I am very surprised that the CEO has not said anything with their plan about going forward. How much they will charge for this treatment? are they applying for approval to the other jurisdictions?
In US alone we have potential of 40K patients who are suitable for this treatment. Same number for Europe. But other regions i have no idea.

How can you make a prediction when the company is silent?

Where do we think this is going ?

CKPT MORE ISSUES....TIMBERRRRRRR

Man , this stock is strange 

CKPT WEEKLY SAR FLIP ALMOST HERE

CKPT WEEKLY NOW BULLISH

CKPT TEST THAT TOP DAILY BAND...THEN THINGS GET INTERESTING

CKPT READY TO EXPLODE NOW FDA APPROVED DRUG

CKPT ISSUES SEEM TO HAVE RESOLVED

I would take that! Thanks !

With today's action I think CKPT is a good candid for BO. Like every other Bios when they got approval followed by a hit and then start going up to get ready for BO.

Someone certainly manipulated the crap out of this one today ! 

Yep. That is usually done on Small Bios. Buy cheap. As i mentioned before it could be one of the HFs since our MC is so low.

It sure seems to me that someone needs more cheap shares today!! 

Thanks Zadie, let's keep the conversation going !! 

I think I am more positive on this than the other poster. Everything takes time. I am just hoping the CEO had a plan for commercialization. As I said before this treatment is good for approx 40K people in US and I do not know how many in other countries. Looking forward hearing something from CEO.

Thanks for the response Chainma !! 

First drug approved for a small bio that will get a very small portion of a potential billion dollar market. Has Checkpoint ever sold anything? What does their sales org look like? Manufacturing?
Pipeline is pretty sparse after this one as well. It's going to be a while before their next approval and this first one isn't going to make them profitable.
Huge win for Checkpoint, there are just a lot of things that need to get done, and the potential sales of this one drug will not get them too far. Of course, we've seen other bios just completely blast off simply on trial results, so I'm not 100% sure why the market is yawning on this one other than it's the end of the year and bios aren't 100% in favor currently.

Someone explain whst the hell is going on here ?  

Seriously yobuck! I can't catch a break ! 

More manipulation for us to endure by shorts and MMs. I think this will play out for the positive much quicker than our other play. Good luck!!!